Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-13
DOI
10.1038/srep29521
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Curcumin Micelles Remodel Tumor Microenvironment and Enhance Vaccine Activity in an Advanced Melanoma Model
- (2016) Yao Lu et al. MOLECULAR THERAPY
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Complete Biochemical Response (Prostate Specific Antigen) to Sipuleucel-T in Metastatic Castrate-Resistant Prostate Cancer: A Case Report With Docetaxel Chemotherapy Administered Just Before Sipuleucel-T
- (2015) Megan McNamara et al. Clinical Genitourinary Cancer
- Myeloid regulatory cells in tumor spreading and metastasis
- (2015) Anton A. Keskinov et al. IMMUNOBIOLOGY
- Curcumin and tumor immune-editing: resurrecting the immune system
- (2015) Sayantan Bose et al. Cell Division
- HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells
- (2015) Junmin Zhou et al. Scientific Reports
- Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)-Specific MHC Class I/II-Restricted Epitopes for Pancreatic Cancer
- (2014) S. Koido et al. CLINICAL CANCER RESEARCH
- Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2014) J.-I. Youn et al. JOURNAL OF IMMUNOLOGY
- The C-type Lectin Receptors Dectin-1, MR, and SIGNR3 Contribute Both Positively and Negatively to the Macrophage Response to Leishmania infantum
- (2013) Lise Lefèvre et al. IMMUNITY
- Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model
- (2013) A. Sevko et al. JOURNAL OF IMMUNOLOGY
- Phase II Trial of Neoadjuvant Docetaxel and CG1940/CG8711 Followed by Radical Prostatectomy in Patients With High-Risk Clinically Localized Prostate Cancer
- (2013) J. Vuky et al. ONCOLOGIST
- Curcumin improves the therapeutic efficacy of Listeriaat-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1
- (2013) Manisha Singh et al. Cancer Medicine
- Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer
- (2013) Yana G. Najjar et al. Frontiers in Oncology
- Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett’s oesophagus
- (2012) Nihit Rawat et al. Clinical & Translational Oncology
- Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro
- (2012) Guang-ju Zhao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Blockade of Myeloid-Derived Suppressor Cells after Induction of Lymphopenia Improves Adoptive T Cell Therapy in a Murine Model of Melanoma
- (2012) K. N. Kodumudi et al. JOURNAL OF IMMUNOLOGY
- Structurally Modified Curcumin Analogs Inhibit STAT3 Phosphorylation and Promote Apoptosis of Human Renal Cell Carcinoma and Melanoma Cell Lines
- (2012) Matthew A. Bill et al. PLoS One
- Clinical trial results of the HER-2/neu(E75) vaccine to prevent breast cancer recurrence in high-risk patients
- (2011) Elizabeth A. Mittendorf et al. CANCER
- Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia
- (2011) R. E. Carroll et al. Cancer Prevention Research
- Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity
- (2011) Feifei Luo et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells
- (2011) Ibrahim Younos et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
- (2010) Mathilde Bayet-Robert et al. CANCER BIOLOGY & THERAPY
- Myeloid-Derived Suppressor Cells in Human Cancer
- (2010) Srinivas Nagaraj et al. CANCER JOURNAL
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
- (2010) K. N. Kodumudi et al. CLINICAL CANCER RESEARCH
- Curcumin Selectively Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines and Patients’ PBMCs: Potential Role for STAT-3 and NF-κB Signaling
- (2010) Chunlei Zhang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
- (2009) P.-Y. Pan et al. CANCER RESEARCH
- The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
- (2009) J. Ozao-Choy et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
- (2009) C. A. Corzo et al. JOURNAL OF IMMUNOLOGY
- Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
- (2008) N. Dhillon et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started